Patent details
EP3527574 Title: ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP3527574
- WO Application Number:
- Type:
- European Patent Granted for NL
- Status:
- Patent in Force
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP19167051.2
- WO Publication Number:
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- United States of America (US)
- Publications:
Dates
- Filing date:
- 18/05/2016
- Grant date:
- 06/04/2022
- EP Publication Date:
- 21/08/2019
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- 30/06/2022
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 06/04/2022
- EP B1 Publication Date:
- 06/04/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 17/05/2036
- Lapsed By Expiration Date:
- Patent Validated Date:
- 14/07/2022
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 11/07/2023
- Name:
- Sumitomo Pharma Oncology, Inc.
- Address:
- 84 Waterford Drive, 01752, Marlborough, MA, United States of America (US)
Historical Applicant/holder
- From:
- 08/09/2022
- To:
- 11/07/2023
- Name:
- Sumitomo Pharma Oncology, Inc.
- Address:
- 640 Memorial Drive, 02139, Cambridge, MA, United States of America (US)
- From:
- 06/04/2022
- To:
- 08/09/2022
- Name:
- Sumitomo Dainippon Pharma Oncology, Inc.
- Address:
- 640 Memorial Drive, Cambridge, MA 02139, United States of America (US)
Agent
1
- Name:
- dr. ir. F.M. van Bouwelen
- From:
- 11/07/2023
- Address:
- Hoffmann Eitle B.V. Weerdestein 97, 1083 GG, AMSTERDAM, Netherlands (NL)
- To:
2
- Name:
- mr. drs. L. van Wezenbeek
- From:
- 13/07/2022
- Address:
- Hoffmann Eitle B.V. Weerdestein 97, 1083 GG, AMSTERDAM, Netherlands (NL)
- To:
- 11/07/2023
Inventor
1
- Name:
- SIDDIQUI-JAIN, Adam
- Address:
- South Jordan, Utah 84095, United States of America (US)
2
- Name:
- BEARSS, David J.
- Address:
- Alpine, Utah 84004, United States of America (US)
Priority
- Priority Patent Number:
- 201562163188 P
- Priority Date:
- 18/05/2015
- Priority Country:
- United States of America (US)
Classification
- IPC or IDT classification:
- C07F 9/12; A61K 31/661; A61P 35/00;
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Journal edition number:
- 39/22
- Publication date:
- 28/09/2022
- Description:
- Changes in the Netherlands Patent Register
2
- Bulletin Heading:
- EP3
- Journal edition number:
- 29/22
- Publication date:
- 20/07/2022
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
- Bulletin Heading:
- EP2
- Journal edition number:
- 14/22
- Publication date:
- 06/04/2022
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
1
- Issue number:
- 202219
- Publication date:
- 11/05/2022
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
2
- Issue number:
- 202214
- Publication date:
- 06/04/2022
- Description:
- Grant (B1)
Deed
Change of Address
- Change Kind/ Decision Type:
- Owner
- Deed Number:
- RC202301525A
- Date Registered:
- 11/07/2023
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. ir. F.M. van Bouwelen
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name
- Deed Number:
- RC202202410A
- Date Registered:
- 08/09/2022
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. ir. F.M. van Bouwelen
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Sumitomo Pharma Oncology, Inc.
- Address:
- 640 Memorial Drive, 02139, Cambridge, MA, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 31/05/2026
- Annual Fee Number:
- 11
- Annual Fee Amount:
- 500 Euro
- Last Annual Payment Date:
- 14/03/2025
- Last Annual Fee Paid Number:
- 10
- Last Annual Fee Paid Amount:
- 400 Euro
- Payer:
- Computer Patent Annuities Limited (CPA)
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 13/07/2022 | Outgoing Correspondence | Letter no formal defects | 1 | /4/3/0/2/8/0800782034/docs/ep19167051.2_0_492804l271.pdf | ||
| 30/06/2022 | Claims | First filed claims | 5 | /4/3/0/2/8/0800782034/docs/ep19167051.2_1_claims20220630154518304.pdf |